{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:01:51Z","timestamp":1794412911108,"version":"4.9.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FDM202306017277"],"award-info":[{"award-number":["FDM202306017277"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to analyse the association between cardiovascular risks factors and the onset of GCA through a systematic review and meta-analysis of observational studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Three databases (Medline, Embase, Web of Science) were systematically reviewed. Epidemiological studies on the association between six cardiovascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, smoking, overweight\/obesity, history of a cardiovascular disease) and the risk of GCA were eligible. Risk of bias was assessed using the ROBINS-E scale. Pooled associations for studies assessing the same outcome were reported as odds ratios (ORs) with their 95% CIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The search strategy identified 4210 references, of which 43 studies were analysed and 17 were included in the meta-analysis (11 case\u2013control studies, 4 cohort studies and 2 cross-sectional studies). An inverse association was found between type 2 diabetes and risk of GCA (OR\u2009=\u20090.75, 95% CI 0.61\u20130.93), whereas history of cardiovascular disease was positively associated with risk of GCA (OR\u2009=\u20091.28, 95% CI 1.18\u20131.38). In addition, the analysis identified a trend towards a decreased risk of GCA in overweight participants (OR 0.64; 95% CI 0.41\u20131.00).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our study showed an inverse association between type 2 diabetes and risk of GCA, and a positive association between a history of cardiovascular disease and risk of GCA. It also identified a trend towards an inverse association between overweight and risk of GCA. The pathophysiological mechanisms underlying these findings may involve an effect of cardiovascular risk factors themselves, a condition underlying these factors (such as diet), or a condition following the diagnosis of cardiovascular disease (such as a treatment).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf164","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:05:54Z","timestamp":1743120354000},"page":"4525-4538","source":"Crossref","is-referenced-by-count":4,"title":["Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-225X","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Barde","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP , Villejuif,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Pacoureau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP , Villejuif,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-5490","authenticated-orcid":false,"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP , Villejuif,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP , Villejuif,","place":["France"]},{"name":"Auto-Immunity Team, IMVA, INSERM U1184 , Le Kremlin Bic\u00eatre,","place":["France"]},{"name":"Department of Rheumatology, H\u00f4pital Bic\u00eatre, AP-HP Sud, Universit\u00e9 Paris Saclay , Le Kremlin-Bic\u00eatre,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-3824","authenticated-orcid":false,"given":"Yann","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Beaujon, AP-HP Nord, Universit\u00e9 Paris Cit\u00e9 , Clichy,","place":["France"]},{"name":"Centre de Recherche en Epid\u00e9miologie et Statistiques (CRESS), Unit\u00e9 Inserm 1153, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"2025080115361602300_keaf164-B1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2009.111005","article-title":"Increase in age at onset of giant cell arteritis: a population-based study","volume":"69","author":"Kermani","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025080115361602300_keaf164-B3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M12-3046","article-title":"Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study","volume":"160","author":"Tomasson","year":"2014","journal-title":"Ann Intern Med"},{"key":"2025080115361602300_keaf164-B4","first-page":"383","article-title":"Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases","volume":"102","author":"Pujades-Rodriguez","year":"2016","journal-title":"Heart Br Card Soc"},{"key":"2025080115361602300_keaf164-B5","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.3390\/jcm11102905","article-title":"New insights into the pathogenesis of giant cell arteritis: mechanisms involved in maintaining vascular inflammation","volume":"11","author":"Greigert","year":"2022","journal-title":"J Clin Med"},{"key":"2025080115361602300_keaf164-B6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1056\/NEJM198107093050216","article-title":"Increased prevalence of HLA-DR4 in giant-cell arteritis","volume":"305","author":"Barrier","year":"1981","journal-title":"N Engl J Med"},{"key":"2025080115361602300_keaf164-B7","doi-asserted-by":"crossref","first-page":"e003493","DOI":"10.1136\/rmdopen-2023-003493","article-title":"Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis","volume":"9","author":"Pacoureau","year":"2023","journal-title":"RMD Open."},{"key":"2025080115361602300_keaf164-B8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3899\/jrheum.220610","article-title":"Lower frequency of comorbidities prior to onset of giant cell arteritis: a population-based study","volume":"50","author":"Elfishawi","year":"2023","journal-title":"J Rheumatol"},{"key":"2025080115361602300_keaf164-B9","first-page":"753","article-title":"Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink","volume":"56","author":"Li","year":"2017","journal-title":"Rheumatology"},{"key":"2025080115361602300_keaf164-B10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/14397595.2015.1081722","article-title":"Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: a systematic review and meta-analysis","volume":"26","author":"Ungprasert","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2025080115361602300_keaf164-B11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/1756-185X.12631","article-title":"Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis","volume":"19","author":"Ungprasert","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"2025080115361602300_keaf164-B12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.semarthrit.2018.07.001","article-title":"Smoking as a risk factor for giant cell arteritis: a systematic review and meta-analysis","volume":"48","author":"Brennan","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B14","doi-asserted-by":"crossref","first-page":"108602","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"2025080115361602300_keaf164-B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1937586717747384","article-title":"How to write a systematic review of the literature","volume":"11","author":"Pati","year":"2018","journal-title":"HERD"},{"key":"2025080115361602300_keaf164-B16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1756-185X.2010.01527.x","article-title":"Lack of association of high body mass index with risk for developing polymyalgia rheumatica","volume":"13","author":"Hoganson","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 9","key":"2025080115361602300_keaf164-B17","volume":"74","author":"Kang","year":"2022"},{"key":"2025080115361602300_keaf164-B18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.semarthrit.2020.05.003","article-title":"Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: a case control and cohort study","volume":"50","author":"Partington","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B19","doi-asserted-by":"crossref","first-page":"rky024","DOI":"10.1093\/rap\/rky024","article-title":"The risk of polymyalgia rheumatica in older adults with gout: a Medicare claims study","volume":"2","author":"Singh","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"2025080115361602300_keaf164-B20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WNO.0000000000000218","article-title":"Effect of diabetes mellitus on giant cell arteritis","volume":"35","author":"Abel","year":"2015","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"key":"2025080115361602300_keaf164-B21","doi-asserted-by":"crossref","first-page":"rkad095","DOI":"10.1093\/rap\/rkad095","article-title":"Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank","volume":"7","author":"Chatzigeorgiou","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"2025080115361602300_keaf164-B22","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X","article-title":"Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l\u2019Art\u00e9rite \u00e0 Cellules G\u00e9antes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B23","doi-asserted-by":"crossref","first-page":"e002640","DOI":"10.1136\/rmdopen-2022-002640","article-title":"Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort","volume":"9","author":"Esen","year":"2023","journal-title":"RMD Open"},{"key":"2025080115361602300_keaf164-B24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/keu331","article-title":"Body mass index and the risk of giant cell arteritis: results from a prospective study","volume":"54","author":"Jakobsson","year":"2015","journal-title":"Rheumatology"},{"key":"2025080115361602300_keaf164-B25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ije\/18.4.836","article-title":"A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?","volume":"18","author":"Machado","year":"1989","journal-title":"Int J Epidemiol"},{"key":"2025080115361602300_keaf164-B26","doi-asserted-by":"crossref","first-page":"rkaa018","DOI":"10.1093\/rap\/rkaa018","article-title":"The relationship between glycated haemoglobin levels and the risk of giant cell arteritis\u2014a case-control study","volume":"4","author":"Mukhtyar","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"2025080115361602300_keaf164-B27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3899\/jrheum.140906","article-title":"Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study","volume":"42","author":"Pugnet","year":"2015","journal-title":"J Rheumatol"},{"key":"2025080115361602300_keaf164-B28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/annrheumdis-2013-204113","article-title":"The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025080115361602300_keaf164-B29","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3899\/jrheum.121150","article-title":"Statin use in giant cell arteritis: a retrospective study","volume":"40","author":"Schmidt","year":"2013","journal-title":"J Rheumatol"},{"key":"2025080115361602300_keaf164-B30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jbspin.2018.05.011","article-title":"The association of gout with incident giant cell arteritis in older adults","volume":"86","author":"Singh","year":"2019","journal-title":"Joint Bone Spine"},{"key":"2025080115361602300_keaf164-B31","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa111.184","article-title":"P189\u2003Diabetes may confer protection from giant cell arteritis: results from a large inception cohort","volume":"59","author":"Spray","year":"2020","journal-title":"Rheumatology"},{"key":"2025080115361602300_keaf164-B32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/03009742.2018.1506821","article-title":"Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study","volume":"48","author":"Tomasson","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2025080115361602300_keaf164-B33","doi-asserted-by":"crossref","first-page":"e001285","DOI":"10.1136\/rmdopen-2020-001285","article-title":"Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study","volume":"6","author":"Turkiewicz","year":"2020","journal-title":"RMD Open."},{"key":"2025080115361602300_keaf164-B34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/acr.22416","article-title":"Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study","volume":"67","author":"Udayakumar","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2025080115361602300_keaf164-B35","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/rheumatology\/keaa080","article-title":"Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis","volume":"59","author":"Wadstr\u00f6m","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"2025080115361602300_keaf164-B36","first-page":"524","article-title":"The association of vascular risk factors with visual loss in giant cell arteritis","volume":"56","author":"Yates","year":"2017","journal-title":"Rheumatology"},{"key":"2025080115361602300_keaf164-B37","author":"World Health Organization. Obesity"},{"key":"2025080115361602300_keaf164-B38","author":"World Health Organization. Cardiovascular diseases (CVDs)"},{"key":"2025080115361602300_keaf164-B39","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J Autoimmun."},{"key":"2025080115361602300_keaf164-B40","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025080115361602300_keaf164-B41","first-page":"1173","article-title":"Smoking and aortic diseases","volume":"71","author":"Kakafika","year":"2007","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"2025080115361602300_keaf164-B42","first-page":"1321","article-title":"The role of tobacco smoking in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review","volume":"42","author":"Moretti","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"2025080115361602300_keaf164-B43","first-page":"232","article-title":"Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis","volume":"3","author":"Ungprasert","year":"2015","journal-title":"Ann Transl Med"},{"key":"2025080115361602300_keaf164-B44","volume-title":"Endotext","author":"Feingold","year":"2000"},{"key":"2025080115361602300_keaf164-B45","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.semarthrit.2021.09.006","article-title":"Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort","volume":"51","author":"Garvey","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted county, Minnesota, 1970\u20131991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"2025080115361602300_keaf164-B48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009742.2014.982701","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009","volume":"44","author":"Chandran","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"2025080115361602300_keaf164-B49","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.ejim.2018.10.004","article-title":"Validation of giant cell arteritis diagnosis code in the French hospital electronic database","volume":"60","author":"Caudrelier","year":"2019","journal-title":"Eur J Intern Med"},{"key":"2025080115361602300_keaf164-B50","doi-asserted-by":"crossref","first-page":"152298","DOI":"10.1016\/j.semarthrit.2023.152298","article-title":"Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: a validation study","volume":"64","author":"Barde","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2025080115361602300_keaf164-B51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","article-title":"Statins and autoimmunity","volume":"56","author":"Khattri","year":"2013","journal-title":"Immunol Res"},{"key":"2025080115361602300_keaf164-B52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2014.03.001","article-title":"Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases","volume":"88","author":"Ulivieri","year":"2014","journal-title":"Pharmacol Res"},{"key":"2025080115361602300_keaf164-B53","doi-asserted-by":"crossref","first-page":"107614","DOI":"10.1016\/j.pharmthera.2020.107614","article-title":"Statins and autoimmunity: state-of-the-art","volume":"214","author":"Dehnavi","year":"2020","journal-title":"Pharmacol Ther"},{"key":"2025080115361602300_keaf164-B54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/ijms24010755","article-title":"Metformin and Its Immune-Mediated Effects in Various Diseases","volume":"24","author":"Nojima","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf164\/62574837\/keaf164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/8\/4525\/62574837\/keaf164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/8\/4525\/62574837\/keaf164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T19:36:29Z","timestamp":1754076989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/8\/4525\/8092566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,3,24]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf164","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,3,24]]}}}